Connor, Clark & Lunn Investment Management (CC&L)
PRAX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Praxis Precision Medicines PRAX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32M Buy
7,194
+324
+5% +$100K 0.01% 918
2025
Q4 		$2.02M Buy
+6,870
New +$1.28M 0.01% 920
2024
Q2 		– Sell
-5,627
Closed -$343K – 1624
2024
Q1 		$343K Sell
5,627
-5,904
-51% -$265K ﹤0.01% 1222
2023
Q4 		$257K Buy
11,531
+7,789
+208% +$140K ﹤0.01% 1209
2023
Q3 		$96K Buy
3,742
+1,162
+45% +$22K ﹤0.01% 1293
2023
Q2 		$44.5K Buy
+2,580
New +$39.5K ﹤0.01% 1274

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return